Genomics and pharmacogenomics in anticancer drug development and clinical response / edited by Federico Innocenti.
Material type:![Text](/opac-tmpl/lib/famfamfam/BK.png)
- 1617376948
- RC271 .G46 2010
Item type | Current library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
![]() |
Kabarak, Main Campus | RC271 .G46 2010 c.1 (Browse shelf(Opens below)) | Available | 34669 |
Browsing Kabarak, Main Campus shelves Close shelf browser (Hides shelf browser)
RC266 .O94 2007 c. 1 Oxford handbook of cancer nursing / | RC267 .C36 2010 Cancer systems biology / | RC271.C5 C44 2012 c.1 The chemotherapy source book / | RC271 .G46 2010 c.1 Genomics and pharmacogenomics in anticancer drug development and clinical response / | RC276 .N38 1983 c. 1 Risk assessment in the Federal Government : | RC280 .G5G96 1992 c. 1 Gynaecological oncology / | RC280 .S5.N68 2008 c.1 Skin cancer / |
Includes bibliographical references and index.
Genomic experimental approaches in oncology -- Pharmacogenomics of toxicity and response of chemotherapy -- Pharmacogenomics in clinical drug development in oncology.
There are no comments on this title.